World Journal of Pharmacology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 852888

Number of visits today: 1153

Number of downloads: 554914

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNAL LIST

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Download full issue 3 (311)

Contents Volume 12 Issue 3 June 16, 2023

Minireviews

Commentary: Discussing the antidepressant potential of silymarin

Claire E Manhard, Brandon Lucke-Wold

World J Pharmacol 12(3):18-24. Published online Jun 16, 2023. doi: 10.5497/wjp.v12.i3.18

Abstract (1139) | Core Tip (1132) | Full Article (HTML) (3653) | Figures (1-1) (733) | Full Article (PDF)-571K (236) | Full Article with Cover (PDF)-762K (220) | Full Article (XML)-94K (158) | Audio-216K (25) | Received: 01/20/2023 | Revised: 05/10/2023 | Accepted: 05/31/2023 | RCA | CrossRef | Google Scholar | Similar Articles (6) | Timeline of Article Publication (0) | Cite | (173) | (164) | (0) | (0) | (0) | (12) | (5065) | Open

Basic Study

In silico insight into Amurensinine - an N-Methyl-D-Aspartate receptor antagonist

Cinthia Façanha Wendel, Queren Hapuque Oliveira Alencar, Rafaela Viana Vieira, Kádima Nayara Teixeira

World J Pharmacol 12(3):25-34. Published online Jun 16, 2023. doi: 10.5497/wjp.v12.i3.25

Abstract (1191) | Core Tip (1081) | Article Highlights (1103) | Full Article (HTML) (2855) | Figures (1-3) (659) | Tables (1-2) (657) | Full Article (PDF)-4737K (250) | Full Article with Cover (PDF)-4929K (211) | Full Article (XML)-109K (173) | Audio-68K (33) | Received: 03/02/2023 | Revised: 05/05/2023 | Accepted: 05/31/2023 | RCA | CrossRef | Google Scholar | Similar Articles (0) | Timeline of Article Publication (1) | Cite | (170) | (168) | (0) | (0) | (0) | (6) | (4877) | Open

Write to the Help Desk

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.